ARLINGTON, Va.— A new report published by the HDA Research Foundation entitled The Role of Reverse Distribution provides insights into the reverse distribution of pharmaceutical products. The Foundation estimates that this channel accounts for 3.5 to 4% of all pharmaceutical sales — more than 120 million product units — and exceeds $13 billion in product value. Reverse distribution
ARLINGTON, Va. — Chain drug stores remain the largest customer segment for U.S. pharmaceutical distributors, according to the HDA Research Foundation. The 88th Edition HDA Factbook (2017‐2018) said chain drug retailers accounted for nearly 30% of all sales to drug distributors last year. Dollar sales to independent pharmacies dipped 1.1%, while sales to hospitals and
Efforts to promote the importation of prescription drugs — seen by some as one way to mitigate the escalating cost of medications — could compromise the safety of the U.S. pharmaceutical supply chain, according to HDA’s John Gray and NACDS’ Steve Anderson. In a blog post on Monday for the policy journal The Hill, Gray,
ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) is conducting a webinar to give an update on the development of its Global Trade Item Number (GTIN) repository service. Held in collaboration with channel data management and analytics solution provider ValueCentric LLC, the free webinar — titled “Origin: HDA’s Product Data Source” — is scheduled for
ARLINGTON, Va. — Later next year, the Healthcare Distribution Alliance (HDA) plans to launch a service to aid the adoption of a Global Trade Item Number (GTIN) coding system across the pharmaceutical supply chain. HDA said Monday that the GTIN Repository Service, prompted by the enactment of the Drug Supply Chain Security Act (DSCSA), will
ARLINGTON, Va. — AmerisourceBergen Corp. was among the winners of the 2016 Distribution Management Award from the Healthcare Distribution Management Association (HDMA). HDMA said Tuesday that AmerisourceBergen received recognition for centralizing its data for Drug Supply Chain Security Act (DSCSA) compliance and preparing for long-term serialization requirements. The award was presented at the HDMA 2016
WASHINGTON — Pharmacies have a four-month extension — until November 1 — to comply with the full scope of new dispenser tracing requirements under the Drug Supply Chain Security Act (DSCSA). The Food and Drug Administration issued a guidance yesterday saying it would not take enforcement action until November against a pharmacy that receives any
ALEXANDRIA, Va. — The National Community Pharmacists Association (NCPA), American Pharmacists Association (APhA) and National Alliance of State Pharmacy Associations (NASPA) have asked the Food and Drug Administration to delay enforcement of a July 1 product tracing deadline for dispensers of pharmaceuticals. In a letter this week to the FDA’s Office of Compliance, the three
WASHINGTON — The Healthcare Distribution Management Association (HDMA) is praising the Food and Drug Administration for its flexibility pertaining to new product tracing rules, specifically on the FDA’s recently released guidance titled “Product Tracing Requirements — Compliance Policy.” The association had sent letters to the regulatory agency in November and then again last month in
